Bvf Inc/Il — 13F Holdings

2026 Q3  ·  48 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, BVF INC/IL maintained a portfolio of 48 distinct positions. The most significant new addition was PYXIS ONCOLOGY INC, now representing 0.91% of the total fund value. They heavily accumulated shares in TYRA BIOSCIENCES INC, increasing the position by 185.6%. Conversely, BVF INC/IL completely exited their position in XOMA ROYALTY CORPORATION.
Position History hover any row below to update
Loading…
BVF INC/IL San Francisco, CA Hedge Fund / Biotech Specialist AUM $3,040M
PCA Score Concentration Risk
Risk ENB
Total Positions
48
Quarter
2026 Q3
Top Holding
RVMD (16.6%)
Top 10 Concentration
66.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-48 of 48

BVF INC/IL Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
RVMD
REVOLUTION MEDI...
Healthcare 16.61% 14.20% #1
Prev: #1
6.5
—
-504,600 -17.0%
P
S
2,460,560 $505,054,546 2020 Q1 13F Filing 2026-09-30 2026-11-16
KYMR
KYMERA THERAPEU...
Healthcare 14.24% 11.35% #2
Prev: #2
6.5
—
no change no change
P
S
3,872,052 $432,856,693 2020 Q3 13F Filing 2026-09-30 2026-11-16
GHRS
GH RESEARCH PLC
Healthcare 6.68% 5.95% #3 2
Prev: #5
4.7
—
no change no change
P
S
8,650,158 $203,105,710 2021 Q2 13F Filing 2026-09-30 2026-11-16
MLTX
MOONLAKE IMMUNO...
Healthcare 6.16% 7.97% #4
Prev: #4
4.0
—
no change no change
P
S
16,001,284 $187,215,023 2022 Q2 13F Filing 2026-09-30 2026-11-16
XNCR
XENCOR INC
Healthcare 5.11% 2.94% #5 4
Prev: #9
3.0
—
-906,686 -12.7%
P
S
6,227,034 $155,364,498 2013 Q4 13F Filing 2026-09-30 2026-11-16
NKTR
NEKTAR THERAPEU...
Healthcare 4.25% 4.27% #6 1
Prev: #7
2.2
—
-257,068 -10.8%
P
S
2,134,007 $129,203,454 2007 Q3 13F Filing 2026-09-30 2026-11-16
ALKS
ALKERMES PLC
Healthcare 3.79% 2.89% #7 3
Prev: #10
4.0
—
692,396 32.1%
P
S
2,847,100 $115,364,492 2026 Q1 13F Filing 2026-09-30 2026-11-16
STOK
STOKE THERAPEUT...
Healthcare 3.09% 2.13% #8 9
Prev: #17
3.7
—
1,061,411 41.7%
P
S
3,608,968 $93,833,168 2025 Q3 13F Filing 2026-09-30 2026-11-16
TYRA
TYRA BIOSCIENCE...
Healthcare 3.03% 1.21% #9 13
Prev: #22
4.2
—
2,739,690 185.6%
P
S
4,215,886 $92,201,427 2021 Q3 13F Filing 2026-09-30 2026-11-16
ZYME
ZYMEWORKS INC
Healthcare 3.02% 2.44% #10 4
Prev: #14
1.7
—
-185,000 -5.1%
P
S
3,464,142 $91,765,122 2022 Q4 13F Filing 2026-09-30 2026-11-16
CGEM
CULLINAN THERAP...
Healthcare 2.90% 2.68% #11 1
Prev: #12
2.2
—
no change no change
P
S
5,750,683 $88,272,984 2021 Q1 13F Filing 2026-09-30 2026-11-16
GPCR
STRUCTURE THERA...
Healthcare 2.77% 4.62% #12 6
Prev: #6
1.1
—
-675,397 -20.1%
P
S
2,691,426 $84,160,891 2023 Q1 13F Filing 2026-09-30 2026-11-16
PVLA
PALVELLA THERAP...
Healthcare 2.75% 2.63% #13
Prev: #13
1.6
—
-65,640 -9.8%
P
S
607,149 $83,744,062 2024 Q4 13F Filing 2026-09-30 2026-11-16
KURA
KURA ONCOLOGY I...
Healthcare 2.36% 2.37% #14 1
Prev: #15
0.9
—
-1,755,661 -20.8%
P
S
6,690,108 $71,651,057 2017 Q3 13F Filing 2026-09-30 2026-11-16
ACIU
AC IMMUNE SA
Healthcare 1.71% 1.21% #15 6
Prev: #21
1.7
—
no change no change
P
S
19,822,436 $51,934,782 2018 Q3 13F Filing 2026-09-30 2026-11-16
GLUE
MONTE ROSA THER...
Healthcare 1.68% 2.76% #16 5
Prev: #11
1.2
—
-184,308 -4.1%
P
S
4,276,578 $51,019,576 2024 Q4 13F Filing 2026-09-30 2026-11-16
ENTX
ENTERA BIO LTD
Healthcare 1.63% 0.11% #17 25
Prev: #42
3.7
—
14,627,893 603.2%
P
S
17,052,893 $49,623,919 2026 Q2 13F Filing 2026-09-30 2026-11-16
OLMA
OLEMA PHARMACEU...
Healthcare 1.51% 1.69% #18
Prev: #18
1.6
—
no change no change
P
S
5,295,893 $45,756,516 2020 Q4 13F Filing 2026-09-30 2026-11-16
N/A
CRESCENT BIOPHA...
Unknown 1.48% 1.27% #19 1
Prev: #20
2.6
—
344,827 12.5%
P
S
3,093,590 $45,135,478 — 13F Filing 2026-09-30 2026-11-16
FDMT
4D MOLECULAR TH...
Healthcare 1.36% 0.98% #20 6
Prev: #26
1.5
—
no change no change
P
S
2,879,289 $41,202,626 2020 Q4 13F Filing 2026-09-30 2026-11-16
IMCR
IMMUNOCORE HLDG...
Healthcare 1.23% 1.05% #21 3
Prev: #24
1.0
—
-63,554 -4.9%
P
S
1,230,909 $37,284,234 2025 Q2 13F Filing 2026-09-30 2026-11-16
ANNX
ANNEXON INC
Healthcare 1.15% 1.27% #22 3
Prev: #19
1.0
—
-420,009 -4.8%
P
S
8,278,164 $35,016,634 2022 Q2 13F Filing 2026-09-30 2026-11-16
MIRM
MIRUM PHARMACEU...
Healthcare 1.15% 3.16% #23 15
Prev: #8
0.5
—
-648,801 -61.4%
P
S
407,226 $34,809,678 2021 Q3 13F Filing 2026-09-30 2026-11-16
SGMT
SAGIMET BIOSCIE...
Healthcare 1.14% 0.49% #24 9
Prev: #33
3.0
—
1,000,000 40.0%
P
S
3,500,000 $34,580,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
PYXS
PYXIS ONCOLOGY ...
Healthcare 0.91% — #25
Prev: #—
3.9
—
11,826,140 —
NEW
11,826,140 $27,554,906 2021 Q4 13F Filing 2026-09-30 2026-11-16
ABSI
ABSCI CORPORATI...
Healthcare 0.84% 0.70% #26 4
Prev: #30
1.3
—
no change no change
P
S
2,361,674 $25,435,229 2026 Q2 13F Filing 2026-09-30 2026-11-16
IVVD
INVIVYD INC
Healthcare 0.81% 0.63% #27 5
Prev: #32
1.3
—
no change no change
P
S
28,165,000 $24,506,367 2025 Q4 13F Filing 2026-09-30 2026-11-16
AVR
ANTERIS TECHNOL...
Healthcare 0.77% 0.76% #28
Prev: #28
1.3
—
no change no change
P
S
3,000,000 $23,310,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
FHTX
FOGHORN THERAPE...
Healthcare 0.69% 0.73% #29
Prev: #29
1.3
—
no change no change
P
S
5,842,000 $20,855,940 2024 Q2 13F Filing 2026-09-30 2026-11-16
STRO
SUTRO BIOPHARMA...
Healthcare 0.66% 1.06% #30 7
Prev: #23
1.3
—
no change no change
P
S
1,251,788 $20,166,305 2019 Q3 13F Filing 2026-09-30 2026-11-16
QTTB
Q32 BIO INC
Healthcare 0.64% 0.77% #31 4
Prev: #27
1.3
—
no change no change
P
S
2,350,000 $19,434,500 2026 Q2 13F Filing 2026-09-30 2026-11-16
ALEC
ALECTOR INC
Healthcare 0.61% — #32
Prev: #—
3.7
—
10,046,206 —
NEW
10,046,206 $18,585,481 2026 Q3 13F Filing 2026-09-30 2026-11-16
ELDN
ELEDON PHARMACE...
Healthcare 0.52% 0.63% #33 2
Prev: #31
1.2
—
no change no change
P
S
6,293,282 $15,922,003 2021 Q1 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
Healthcare 0.50% 2.16% #34 18
Prev: #16
0.2
—
-920,312 -79.8%
P
S
233,300 $15,271,818 2025 Q4 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 0.46% 0.98% #35 10
Prev: #25
0.2
—
-1,168,139 -56.3%
P
S
907,406 $13,910,534 2024 Q3 13F Filing 2026-09-30 2026-11-16
OKUR
ONKURE THERAPEU...
Healthcare 0.36% 0.38% #36 2
Prev: #34
2.6
—
809,500 25.0%
P
S
4,045,278 $11,023,383 2026 Q1 13F Filing 2026-09-30 2026-11-16
IMUX
IMMUNIC INC
Healthcare 0.23% 0.30% #37 2
Prev: #35
1.1
—
no change no change
P
S
765,295 $7,117,244 2022 Q4 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 0.21% — #38
Prev: #—
3.6
—
500,000 —
NEW
500,000 $6,255,000 — 13F Filing 2026-09-30 2026-11-16
N/A
RESEARCH ALLIAN...
Unknown 0.19% — #39
Prev: #—
3.6
—
500,000 —
NEW
500,000 $5,920,000 — 13F Filing 2026-09-30 2026-11-16
N/A
RESEARCH ALLIAN...
Unknown 0.18% 0.14% #40 1
Prev: #39
1.1
—
no change no change
P
S
500,000 $5,355,000 — 13F Filing 2026-09-30 2026-11-16
MOLN
MOLECULAR PARTN...
Healthcare 0.17% 0.13% #41 1
Prev: #40
1.1
—
no change no change
P
S
1,353,968 $5,185,697 2021 Q3 13F Filing 2026-09-30 2026-11-16
IMA
IMAGENEBIO INC
Healthcare 0.17% 0.17% #42 5
Prev: #37
1.1
—
no change no change
P
S
1,110,002 $5,083,809 2025 Q3 13F Filing 2026-09-30 2026-11-16
XFOR
X4 PHARMACEUTIC...
Healthcare 0.15% 0.27% #43 7
Prev: #36
0.1
—
-657,118 -29.4%
P
S
1,576,624 $4,572,210 2025 Q3 13F Filing 2026-09-30 2026-11-16
IVA
INVENTIVA SA
Healthcare 0.08% 0.07% #44 1
Prev: #43
1.0
—
no change no change
P
S
686,040 $2,531,488 2021 Q1 13F Filing 2026-09-30 2026-11-16
TCRX
TSCAN THERAPEUT...
Healthcare 0.06% 0.14% #45 7
Prev: #38
1.0
—
no change no change
P
S
5,564,290 $1,749,969 2023 Q2 13F Filing 2026-09-30 2026-11-16
N/A
ENGENE THERAPEU...
Unknown 0.01% 0.01% #46 2
Prev: #44
1.0
—
no change no change
P
S
945,402 $189,175 — 13F Filing 2026-09-30 2026-11-16
TENX
TENAX THERAPEUT...
Healthcare 0.00% 0.13% #47 6
Prev: #41
0.0
—
-314,549 -92.6%
P
S
25,000 $47,250 2024 Q3 13F Filing 2026-09-30 2026-11-16
XOMA
XOMA ROYALTY CO...
Healthcare 0.00% 8.25%
Sold All 😨
(Was: #3)
0.0
—
-7,593,303 -100.0%
CLOSED
— $— 2016 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-48 of 48 holdings

Unlock Full BVF INC/IL Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →